Breast Implant–Associated Infections
Authors:
- Cathy CarrollCCCathy Carroll
- Marissa M. TenenbaumMTMarissa M. Tenenbaum
- Terence M. MyckatynTMTerence M. Myckatyn
- 1 November 2015
- journal article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 136 (5) , 921-929
Abstract
The most common cause of surgical readmission after breast implant surgery remains infection. Six causative organisms are principally involved: Staphylococcus epidermidis and S. aureus, Escherichia, Pseudomonas, Propionibacterium, and Corynebacterium. The authors investigated the infection patterns and antibiotic sensitivities to characterize their local microbiome and determine ideal antibiotic selection. A retrospective review of 2285 consecutive implant-based breast procedures was performed. Included surgical procedures were immediate and delayed breast reconstruction, tissue expander exchange, and cosmetic augmentation. Patient demographics, chemotherapy and/or irradiation status, implant characteristics, explantation reason, time to infection, microbiological data, and antibiotic sensitivities were reviewed. Forty-seven patients (2.1 percent) required inpatient admission for antibiotics, operative explantation, or drainage by interventional radiology. The infection rate varied depending on surgical procedure, with the highest rate seen in mastectomy and immediate tissue expander reconstruction (6.1 percent). The mean time to explantation was 41 days. Only 50 percent of infections occurred within 30 days of the indexed National Surgical Quality Improvement Program operation. The most commonly isolated organisms were coagulase-negative Staphylococcus (27 percent), methicillin-sensitive S. aureus (25 percent), methicillin-resistant S. aureus (7 percent), Pseudomonas (7 percent), and Peptostreptococcus (7 percent). All Gram-positive organisms were sensitive to vancomycin, linezolid, tetracycline, and doxycycline; all Gram-negative organisms were sensitive to gentamicin and cefepime. Empiric antibiotics should be vancomycin (with the possible inclusion of gentamicin) based on their broad effectiveness against the authors' unique microbiome. Minor infections should be treated with tetracycline or doxycycline as a second-line agent. National Surgical Quality Improvement Program data are adequate for monitoring and comparing breast infections but certainly not comprehensive. Therapeutic, IV.Keywords
This publication has 22 references indexed in Scilit:
- Infection following Implant-Based Reconstruction in 1952 Consecutive Breast ReconstructionsPlastic and Reconstructive Surgery, 2013
- Breast Implant InfectionsInfectious Disease Clinics of North America, 2012
- Extended Trimethoprim/Sulfamethoxazole Prophylaxis for Implant Reconstruction in the Previously Irradiated Chest WallPlastic and Reconstructive Surgery, 2012
- Subclinical (Biofilm) Infection Causes Capsular Contracture in a Porcine Model following Augmentation MammaplastyPlastic and Reconstructive Surgery, 2010
- Effect of Postdischarge Morbidity and Mortality on Comparisons of Hospital Surgical QualityAnnals of Surgery, 2010
- Management of the Infected or Exposed Breast Prosthesis: A Single Surgeonʼs 15-Year Experience with 69 PatientsPlastic and Reconstructive Surgery, 2010
- Does Surgical Quality Improve in the American College of Surgeons National Surgical Quality Improvement ProgramAnnals of Surgery, 2009
- Microbial Evaluation: 139 Implants Removed from Symptomatic PatientsPlastic and Reconstructive Surgery, 1996
- Salvage of the Exposed Breast ImplantAnnals of Plastic Surgery, 1986
- Capsules, Infection, and Intraluminal AntibioticsPlastic and Reconstructive Surgery, 1981